OHSU in the news

Emailing your doctor may carry a fee

The New York Times January 24, 2023
OHSU is mentioned in a New York Times story on U.S. hospitals beginning to charge patients for exchanging electronic messages with their providers. To both help patients receive the best and most appropriate kind of care for their specific situation as well as to help providers better balance patient care responsibilities, OHSU began a pilot in September 2022 that involves billing some patients for the time it takes clinicians at two outpatient clinics to respond to more complex inquiries that are submitted through the OHSU MyChart electronic health portal.

At OHSU, researchers test a promising Alzheimer’s drug — and search for a cause

Oregon Public Broadcasting January 24, 2023
Researchers at OHSU are contributing to an international clinical trial exploring possible treatments for Alzheimer’s, specifically focusing on earlier intervention. The AHEAD Study looks at the treatment of a drug called Lecanemab, which could delay memory decline before symptoms of the disease appear.

Pharmacists talk effectiveness of opioid overdose reversal drug ahead of FDA review

KATU-TV January 24, 2023
In a story about FDA advisers possibly making the overdose-reversing nasal spray naloxone available over the counter, Emily Skogrand, Pharm.D., says it can be made more available by reducing its cost or even making it free, adding: “I also do think on some level, making it [available] over the counter so you don't have to go to the pharmacy and potentially feel judged or stigmatized. You can just buy it like you buy Tylenol or Ibuprofen that would still have a cost associated, should associated [be] with it, but hopefully less."

Pharmacists talk effectiveness of opioid overdose reversal drug ahead of FDA review

KTVL-TV January 24, 2023
In a story about FDA advisers possibly making the overdose-reversing nasal spray naloxone available over the counter, Emily Skogrand, Pharm.D., says it can be made more available by reducing its cost or even making it free, adding: “I also do think on some level, making it [available] over the counter so you don't have to go to the pharmacy and potentially feel judged or stigmatized. You can just buy it like you buy Tylenol or Ibuprofen that would still have a cost associated, should associated [be] with it, but hopefully less."

State’s respiratory surge slows, but battle continues

(Coos Bay) The World January 20, 2023
News briefing held by Oregon Health Authority cites Jan. 6 statewide forecast by Peter Graven, Ph.D., predicting a small increase in the number of people hospitalized with COVID-19 due to the XBB.1.5 variant.
See more stories